<DOC>
	<DOCNO>NCT01768611</DOCNO>
	<brief_summary>Cells damage hyperglycemia unable downregulate glucose entrance presence high extracellular glucose result intracellular activation deleterious biochemical pathway . Expression GLUT-1 , major glucose transporter mesangial cell , increase participates induction diabetic nephropathy . Variants gene encode GLUT-1 ( SLC2A1 ) associate diabetic complication . The aim study test whether polymorphism SLC2A1 confer susceptibility diabetic nephropathy Brazilian type 1 diabetes patient .</brief_summary>
	<brief_title>SLC2A1 Variants Diabetic Nephropathy</brief_title>
	<detailed_description>In study , 449 patient , include October 2004 October 2012 , sort three group accord diabetic nephropathy stage : without ( persistent normoalbuminuria , n=248 ) , incipient ( microalbuminuria , n=82 ) overt diabetic nephropathy ( macroalbuminuria proteinuria renal replacement therapy , n=119 ) . Measurements urinary albumin-to-creatinine ratio ( ACR ) urinary albumin excretion rate ( UAER ) use define DN : patient persistent normoalbuminuria ( &lt; 30 mg/g creatinine &lt; 20 μg/min ) classify without DN ( n=248 ) ; patient present persistent microalbuminuria ( 30-300 mg/g creatinine 20-200 μg/min ) classify incipient DN ( n=82 ) ; patient present persistent macroalbuminuria ( &gt; 300 mg/g creatinine &gt; 200 µg/min ) , proteinuria ( &gt; 500 mg/24 h ) renal replacement therapy classify overt DN ( n=119 ) . Genotyping polymorphism perform Real Time PCR use fluorescent -labelled probe .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Overt 10 year Diabetes Mellitus Patients present autoimmune disease , HIV HCV infection Patients glomerular filtration rate &lt; 60 mL min−1 1.73 m2 without diabetic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>